Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company General Electric Co.
DescriptionImmunohistochemical test to determine if breast cancer patients will respond to taxane therapy
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose if breast cancer will respond to taxane therapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today